Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
2356
Gupta P, Hameed S and Jain R. Ring-substituted imidazoles as a new class of anti-tuberculosis agents European Journal of Medicinal Chemistry 2004, 39, 805-814.
2357
Gupta P, Kakumanu VK and Bansal AK. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective Pharmaceutical Research 2004, 21, 1762-1769.
2358
Gupta S, Kaul CL and Sharma SS. Neuroprotective effect of combination of poly (ADP ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats Neurological Research 2004, 26, 103-107.
2359
Jain AK and Panchagnula R. Combination strategy of penetration enhancement for transdermal delivery: studies with imipramine hydrochloride Pharmaceutical Industry 2004, 66, 478-482.
2360
Jain M, Vangapandu S, Sachdeva S and Jain R. Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates Bioorganic & Medicinal Chemistry 2004, 12, 1003-1010.
2361
Jain M, Vangapandu S, Sachdeva S, Singh S, Singh PP, Gena GB, Tikoo K, Ramarao P, Kaul CL and Jain R. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity Journal of Medicinal Chemistry 2004, 47, 285-287.
2362
Jayanarayan KG and Dey CS. Altered expression, polymerisation and cellular distribution of [alpha]-/[beta]-tubulins and apoptotic-like cell death in arsenite resistant Leishmania donovani promastigotes International Journal for Parasitology 2004, 34, 915-925.
2363
Kabra DG, Thiyagarajan M, Kaul CL and Sharma SS. Neuroprotective effect of 4-Amino-1,8-napthalimide, a poly (ADP ribose) polymerase inhibitor in middle cerebral artery occlusion induced focal cerebral ischemia in rat Brain Research Bulletin 2004, 62, 425-433.
2364
Kakumanu VK and Bansal AK. Supercritical Fluid Technology in Pharmaceutical Research Business briefings: Labtech 2004, .
2365
Kashyap N, Kumar N and Ravi Kumar MNV. Drug Delivery Technology 2004, 4, 32-39.
2366
Kaul P, Banerjee A and Banerjee UC. Opportunities for the Pharmaceutical Industry: Key Biotransformation Technologies of the Future Drug Discovery World 2004, 5, 80-86.
2367
Kaul P, Banerjee A, Mayilraj S and Banerjee UC. Screening for enantioselective nitrilases: kinetic resolution of racemic mandelonitrile to (R)-(-)-mandelic acid by new bacterial isolates Tetrahedron Asymmetry 2004, 15, 207-211.
2368
Kaur A, Kinhikar AG and Singh PP. Bioimmunotherapy of rodent malaria: co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly Acta Tropica 2004, 91, 27-41.
2369
Kaur N, Monga V and Jain R. Facile one-step synthesis of N-α-Boc-1-alkyl-L-histidines Tetrahedron Letters 2004, 45, 6883-6885.
2370
Kaur S and Singh PP. Serum amyloid P-component-mediated inhibition of the uptake of Mycobacterium tuberculosis by macrophages, in vitro Scandinavian Journal Of Immunology 2004, 59, 425-431.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|158|15